Hormone Receptor Expression Variations in Normal Breast Tissue: Preliminary Results of a Prospective Observational Study
- PMID: 34066838
- PMCID: PMC8150273
- DOI: 10.3390/jpm11050387
Hormone Receptor Expression Variations in Normal Breast Tissue: Preliminary Results of a Prospective Observational Study
Abstract
Normal breast tissue undergoes great variations during a woman's life as a consequence of the different hormonal stimulation. The purpose of the present study was to examine the hormonal receptor expression variations according to age, menstrual cycle, menopausal state and body mass index. To this purpose, 49 tissue samples of normal breast tissue, obtained during surgery performed for benign and malignant conditions, were immunostained with Estrogen (ER), Progesterone (PR) and Androgen receptors (AR). In addition, Ki67 and Gross Cystic Disease Fluid Protein were studied. The data obtained revealed a great variability of hormone receptor expression. ER and AR generally increased in older and post-menopausal women, while young women presented a higher proliferative rate, evaluated with Ki67. PR increase was observed in women with BMI higher than 25. The different hormonal receptor expression could favor the development of breast cancer.
Keywords: breast cancer; breast pathology; hormone expression; hormone receptor; normal breast.
Conflict of interest statement
Disclosure of financial interests and potential conflicts of interest. MPF received grants from Roche, Devicor Mammotome as support for course organization and participation, and from MSD and Biocartis as speaker fee. All the remaining authors submitting this manuscript confirm and attest that they have no conflict of interest. There are no source of support in any form nor funding for this work. There are no financial relation-ships for this work.
Similar articles
-
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.Cancer Res. 1979 May;39(5):1447-54. Cancer Res. 1979. PMID: 427788
-
Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach.Int J Cancer. 1986 Nov 15;38(5):637-42. doi: 10.1002/ijc.2910380504. Int J Cancer. 1986. PMID: 3770993
-
Fallopian tube epithelial cells express androgen receptor and have a distinct hormonal responsiveness when compared with endometrial epithelium.Hum Reprod. 2020 Sep 1;35(9):2097-2106. doi: 10.1093/humrep/deaa177. Hum Reprod. 2020. PMID: 32876325
-
Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory.Future Oncol. 2008 Feb;4(1):15-21. doi: 10.2217/14796694.4.1.15. Future Oncol. 2008. PMID: 18240997 Review.
-
Post-menopausal breast cancer: from estrogen to androgen receptor.Oncotarget. 2017 Oct 27;8(60):102739-102758. doi: 10.18632/oncotarget.22156. eCollection 2017 Nov 24. Oncotarget. 2017. PMID: 29254284 Free PMC article. Review.
Cited by
-
Innovations in the Integrated Management of Breast Cancer.J Pers Med. 2022 Mar 28;12(4):531. doi: 10.3390/jpm12040531. J Pers Med. 2022. PMID: 35455647 Free PMC article.
-
Lactating Adenoma Arising From Ovarian Mature Teratoma: An Unusual Presentation of a Young Pregnant Woman.Cureus. 2024 Jul 31;16(7):e65846. doi: 10.7759/cureus.65846. eCollection 2024 Jul. Cureus. 2024. PMID: 39219914 Free PMC article.
-
The relationship between night shift work and breast cancer incidence: A systematic review and meta-analysis of observational studies.Open Med (Wars). 2022 Apr 8;17(1):712-731. doi: 10.1515/med-2022-0470. eCollection 2022. Open Med (Wars). 2022. PMID: 35702390 Free PMC article.
-
Design and synthesis of phosphoryl-substituted steroidal pyridazines (Pho-STPYRs) as potent estrogen receptor alpha inhibitors: targeted treatment of hormone-dependent breast cancer cells.RSC Med Chem. 2024 Jun 3;15(7):2380-2399. doi: 10.1039/d4md00153b. eCollection 2024 Jul 17. RSC Med Chem. 2024. PMID: 39026643 Free PMC article.
References
-
- American Cancer Society . Breast Cancer Facts & Figure 2015–Figure 2016. American Cancer Society; Atlanta, GA, USA: 2015.
-
- Howlader N.A., Krapcho M., Miller D. SEER Cancer Statistics Review, 1975–2014; National Cancer Institute: Bethesda, MD, USA. [(accessed on 2 February 2021)]; Available online: https://seer.cancer.gov/csr/1975_2014/
LinkOut - more resources
Full Text Sources
Research Materials